Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (10138)	5/21/1999 11:33:00 AM
From: PrometheusTex	Read Replies (1) \| Respond to of 17367

I am afraid I was not there. I am told that the reperfusion of limbs was dramatic and obvious. With some hyperbole, it is said that is was almost as if it were occurring in the same moment. I am also told that there is a kind of inevitable progress as menin. progresses; a good critical care unit with some experience anticipates the progression by the clock. The kids that got Neuprex fairly quickly broke out of this pattern. With regard to the earlier discussion about shock in the absence of bacteria, it seems there is an example of inducing fatal shock using two precisely timed doses of IL-1; I recall that this experiment looked like what happens in sepsis, but I have not found the reference. Any help? ProTex

To: Bluegreen who wrote (10138)	5/21/1999 9:56:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Think XOMA is very confident and self assured that there have been no leaks about anything. Think it checks with Murphy, and others to see what they know. XOMA then upon finding that none of the people they contact know Jack about what is going on gets even more pleased with itself. From this one could conclude that there is something worth leaking. The act of concealing implies something important, needing concealment. BTW it was my impression that the sloppy, vague way accrual numbers are referred to for the TRAUMA trials indicated something. XOMA intentionally is no longer providing this information as some at XOMA maintain shareholders do not need this level of detail!!!!!!!! Still cannot get over the fact that despite all the explanations saying, institutional investors would not buy under $5 nor before approval we have seen considerable interest by institutions.